WallStSmart

Chime Financial, Inc. Class A Common Stock (CHYM)vsSalesforce.com Inc (CRM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Salesforce.com Inc generates 1688% more annual revenue ($43.94B vs $2.46B). CRM leads profitability with a 22.0% profit margin vs -0.7%. CHYM trades at a lower P/E of 6.3x. CRM earns a higher WallStSmart Score of 74/100 (B).

CHYM

Hold

36

out of 100

Grade: F

Growth: 6.7Profit: 5.0Value: 6.7Quality: 6.5
Piotroski: 2/9Altman Z: -0.66

CRM

Strong Buy

74

out of 100

Grade: B

Growth: 7.3Profit: 8.0Value: 8.0Quality: 4.5
Piotroski: 5/9Altman Z: 1.50
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CHYM.

CRMUndervalued (+65.7%)

Margin of Safety

+65.7%

Fair Value

$721.77

Current Price

$247.72

$474.05 discount

UndervaluedFair: $721.77Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CHYM3 strengths · Avg: 9.3/10
P/E RatioValuation
6.3x10/10

Attractively priced relative to earnings

Debt/EquityHealth
0.0910/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
26.8%8/10

Revenue surging 26.8% year-over-year

CRM6 strengths · Avg: 9.0/10
Market CapQuality
$203.87B10/10

Mega-cap, among the largest globally

EPS GrowthGrowth
118.9%10/10

Earnings expanding 118.9% YoY

Return on EquityProfitability
25.2%9/10

Every $100 of equity generates 25 in profit

Profit MarginProfitability
22.0%9/10

Keeps 22 of every $100 in revenue as profit

PEG RatioValuation
0.908/10

Growing faster than its price suggests

Operating MarginProfitability
21.4%8/10

Strong operational efficiency at 21.4%

Areas to Watch

CHYM4 concerns · Avg: 2.8/10
Price/BookValuation
8.9x4/10

Trading at 8.9x book value

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-1.3%2/10

ROE of -1.3% — below average capital efficiency

EPS GrowthGrowth
-33.8%2/10

Earnings declined 33.8%

CRM2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.504/10

Distress zone — elevated risk

Debt/EquityHealth
1.093/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : CHYM

The strongest argument for CHYM centers on P/E Ratio, Debt/Equity, Revenue Growth. Revenue growth of 26.8% demonstrates continued momentum.

Bull Case : CRM

The strongest argument for CRM centers on Market Cap, EPS Growth, Return on Equity. Profitability is solid with margins at 22.0% and operating margin at 21.4%. Revenue growth of 10.8% demonstrates continued momentum.

Bear Case : CHYM

The primary concerns for CHYM are Price/Book, Piotroski F-Score, Return on Equity.

Bear Case : CRM

The primary concerns for CRM are Altman Z-Score, Debt/Equity.

Key Dynamics to Monitor

CHYM profiles as a growth stock while CRM is a mature play — different risk/reward profiles.

CHYM is growing revenue faster at 26.8% — sustainability is the question.

CRM generates stronger free cash flow (1.1B), providing more financial flexibility.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CRM scores higher overall (74/100 vs 36/100), backed by strong 22.0% margins and 10.8% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Chime Financial, Inc. Class A Common Stock

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Chime Financial, Inc., a financial technology company, provides digital consumer banking and payment solutions. The company is headquartered in San Francisco, California.

Salesforce.com Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Salesforce.com, Inc. is an American cloud-based software company headquartered in San Francisco, California. It provides customer relationship management (CRM) service and also provides a complementary suite of enterprise applications focused on customer service, marketing automation, analytics, and application development.

Visit Website →

Want to dig deeper into these stocks?